Histidine

Histidine

SCHEMBL19209941

NC(CCC(=O)O)C(=O)O.N[C@@H](Cc1c[nH]cn1)C(=O)O

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.51
GRM8 O00222 2/20 0.51
GRM6 O15303 2/20 0.51
GRM7 Q14831 2/20 0.51
GRM4 Q14833 2/20 0.51
GRIA1 P42261 2/20 0.51
GRIA2 P42262 2/20 0.51
GRIA3 P42263 2/20 0.51
GRIA4 P48058 2/20 0.51
GRIN2D O15399 1/20 0.51
GRIN3B O60391 1/20 0.51
GSR P00390 1/20 0.51
GRIK1 P39086 1/20 0.51
GRM5 P41594 1/20 0.51
SLC1A3 P43003 1/20 0.51
SLC1A2 P43004 1/20 0.51
SLC1A1 P43005 1/20 0.51
GRIN1 Q05586 1/20 0.51
GRIN2A Q12879 1/20 0.51
GRIK2 Q13002 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Histidine SCHEMBL2228115 1.00 CYP1A2 (0.51) CYP1A2GRM8GRM6GRM7GRM4
Histidine SCHEMBL4356748 1.00 CYP1A2 (0.51) CYP1A2GRM8GRM6GRM7GRM4
Histidine SCHEMBL23306565 1.00 CYP1A2 (0.51) CYP1A2GRM8GRM6GRM7GRM4
Histidine SCHEMBL23291081 0.99 CYP1A2 (0.50) CYP1A2GRM8GRM6GRM7GRM4
Histidine SCHEMBL5670423 0.95 CYP1A2 (0.46) CYP1A2GRM8GRM6GRM7GRM4
Histidine SCHEMBL2730156 0.95 ALOX15 (0.49) CYP1A2GRM8GRM6GRM7GRM4
Histidine SCHEMBL4229349 0.95 CYP1A2 (0.46) CYP1A2GRM8GRM6GRM7GRM4
Histidine SCHEMBL2727906 0.95 ALOX15 (0.49) CYP1A2GRM8GRM6GRM7GRM4
Histidine SCHEMBL9389369 0.95 ALOX15 (0.49) CYP1A2GRM8GRM6GRM7GRM4
Histidine SCHEMBL17981689 0.95 GRIA1 (0.46) CYP1A2GRM8GRM6GRM7GRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11285210-B2 Buffer formulations for enhanced antibody stability OUTLOOK THERAPEUTICS, INC. (US) 2022-03-29 US disclosed
US-20190030163-A1 BUFFER FORMULATIONS FOR ENHANCED ANTIBODY STABILITY OUTLOOK THERAPEUTICS, INC. 2019-01-31 US disclosed
EP-3411401-A1 BUFFER FORMULATIONS FOR ENHANCED ANTIBODY STABILITY Oncobiologics, Inc. (US) 2018-12-12 EP disclosed
WO-2017136433-A1 BUFFER FORMULATIONS FOR ENHANCED ANTIBODY STABILITY ONCOBIOLOGICS, INC. (US) 2017-08-10 WO disclosed